Influence of cardiovascular absolute risk assessment on prescribing of antihypertensive and lipid-lowering medications: A cluster randomized controlled trial

American Heart Journal

Volumn 167, Issue 1, 2014, Pages 28-35

  Vagholkar, Sanjyot ^a,b   Zwar, Nicholas ^b   Jayasinghe, Upali W ^b   Denney Wilson, Elizabeth ^c   Patel, Anushka ^d   Campbell, Terry ^b   Harris, Mark F ^b  

^a General Practice Unit   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; AUSTRALIA; BLOOD PRESSURE; CARDIOVASCULAR RISK; CONSULTATION; CONTROLLED STUDY; ELECTRONIC PRESCRIBING; FEMALE; FOLLOW UP; GENERAL PRACTICE; GENERAL PRACTITIONER; HEALTH CARE PLANNING; HUMAN; HYPERTENSION; INTERVENTION STUDY; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; MEDICAL EXAMINATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; TREATMENT DURATION;

AGED; ANTIHYPERTENSIVE AGENTS; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; HYPOLIPIDEMIC AGENTS; LOGISTIC MODELS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; RISK ASSESSMENT;

EID: 84890130577     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2013.10.002     Document Type: Article

References (32)

1. R. Lozano, M. Naghavi, and K. Foreman Global mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 Lancet 380 2012 2095 2128
2. V.L. Roger, A.S. Go, and D.M. Lloyd-Jones Heart disease and stroke statistics - 2012 update: a report from the american heart association Circulation 125 2012 e2 e220
3. Australian Institute of Health & Welfare Australia's health 2012 Australia's health series no 13. Cat. no. AUS 156 2012 AIHW Canberra
4. A.V. Chobanian, G.L. Bakris, and H.R. Black The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: the JNC7 report JAMA 289 2003 2560 2572
5. Third Report of the National Cholesterol Education Program (NCEP) Expert Panal on Detection, Evaluation and Treatment of High Blood Cholesterl in Adults (Adult Treatment PaneI III) 2002 http://www.nhlbi.nih.gov/guidelines/ cholesterol/atp3-rpt.htm (Accessed 29/9/2013).
6. National Heart Foundation of Australia (National Blood Pressure and Vascular Disease Advisory Committee). Guide to management of blood pressure 2008. Updated December 2010. http://www.heartfoundation.org.au/ SiteCollectionDocuments/HypertensionGuidelines2008to2010Update.pdf (Accessed 29/9/2013).
7. Position Statement on Lipid Management National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand Heart Lung and Circulation 14 2005 275 291
8. J. Ma, N.L. Sehgal, and J.Z. Ayanian National trends in statin use by coronary heart disease risk category PLoS Med 2 2005 e123
9. E.L. Heeley, D.P. Peiris, and A. Patel Cardiovascular risk perception and evidence-practice gaps in Australian general practice (the AusHEART study) Med J Aust 192 2010 254 259
10. P. Brindle, A. Beswick, and T. Fahey Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review Heart 92 2006 1752 1759
11. S.L. Sheridan, and E. Crespo Does the routine use of global coronary heart disease risk scores translate into clinical benefits or harms? A systematic review of the literature BMC Health Services Research 8 60 2008
12. L.M.L. Hall, R.T. Jung, and G.P. Leese Controlled trial of effect of documented cardiovascular risk scores on prescribing BMJ 326 2003 251 252
13. A.A. Montgomery, T. Fahey, and T.J. Peters Evaluation of computer based clinical decision support system and risk chart for management of hypertension in primary care: randomised controlled trial BMJ 320 2000 686 690
14. B. Shillinglaw, A.J. Viera, and T. Edwards Use of global coronary heart disease risk assessment in practice: a cross sectional survey of a sample of US physicians BMC Health Services Research 12 20 2012
15. R. Gupta, N.P. Stocks, and J. Broadbent Cardiovascular risk assessment in Australian general practice Aust Fam Physician 38 2009 364 368
16. D. Torley, N.A. Zwar, and E.J. Comino General practitioners views of absolute cardiovascular risk and its role in primary prevention Aust Fam Physician 34 2005 503 505
17. Q. Wan, M.F. Harris, and N. Zwar Study protocol for a randomised controlled trial: the feasibility and impact of cardiovascular absolute risk assessment in Australian general practice Am Heart J 157 2009 436 441
18. New Zealand cardiovascular risk charts. www.health.govt.nz/publication/ new-zealand-cardiovascular-risk-charts. Accessed August 29, 2013.
19. M. Moerbeek The consequences of ignoring a level of nesting in multilevel analysis Multivariate Behavioural Research 39 2004 129 149
20. PILL Collaborative Group An international randomised placebo-controlled trial of a four-component combination pill ("Polypill") in people with raised cardiovascular risk PLoS ONE 6 5 2011 e19857 10.1371/journal.pone. 0019857
21. H. Britt, G.C. Miller, and J. Henderson Genral practice activity in Australia 2009-10. General practice series no. 27. Cat. no. GEP 27 2010 AIHW Canberra
22. H. Doroodchi, M. Abdolrasulna, and J.A. Foster Knowledge and attitudes of primary care physicians in the management of patients at risk of cardiovascular events BMC Family Practice 9 42 2008
23. R.J. Webster, E.L. Heeley, and D.P. Peiris Gaps in cardiovascular disease risk management in Australian general practice Med J Aust 191 2009 324 329
24. N. Rafter, J. Connor, and J. Hall Cardiovascular medications in primary care: treatment gaps and targeting by absolute risk The New Zealand Medical Journal 118 1223 2005
25. F.D.R. Hobbs, J.W. Jukema, and P.M. Da Silva Barriers to cardiovascular disease risk scoring and primary prevention in Europe Q J Med 103 2010 727 739
26. K. Eichler, M. Zoller, and P. Tschudi Barriers to apply cardiovascular prediction rules in primary care: a postal survey BMC Family Practice 8 1 2007
27. P. Bastholm Rahmner, L.L. Gustafsson, and J. Lassson Variations in understanding the drug-prescribing process: a qualitative study among Swedish GPs Fam Pract 26 2009 121 127
28. C. Oriel-Zerbe, and H.H. Abholz Primary prevention of cardiovascular diseases by lipid-lowering treatment in German general practice: results from GPs ignoring guidelines and risk calculators European Journal of General Practice 13 2007 27 34
29. P. Cacoub, E. Tocque-Le Gousse, and C. Fabry Application in general practice of treatment guidelines for patients with dyslipidaemia: the RESPECT study Archives of Cardiovascular Disease 101 2008 715 721
30. M. Brekke, and J. Straand Does present use of cardiovascular medication reflect elevated cardiovascular risk scores estimated ten years ago? A population based longitudinal study BMC Public Health 11 144 2011
31. M.F. Harris, M. Fanaian, and U.W. Jayasinghe A cluster randomized controlled trial of vascular risk factor management in general practice Med J Aust 197 2012 387 393
32. National Vascular Disease Prevention Alliance. Guidelines for the management of absolute cardiovascular disease risk 2012. http:// strokefoundation.com.au/site/media/AbsoluteCVD-GL-webready.pdf. Accessed August 29, 2013).